🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Hear from the POC members why you should definitely come to the #ENEA2024 Congress in Sevilla 🇪🇸 enea2024.com/interviews/

…. this dream team will do great!

Register until July 19 to take advantage of the Early-Bird fee 🦉 enea2024.com/registration/

Take advantage of the Early Bird fee until July 31 enea2024.com/registration/

#CoMICWednesday #EJECoMICs Ep 47: NEW Euro J Endocrinology paper: Whole blood transcriptomic signature of Cushing's syndrome Watch 👉 youtu.be/4iwawBsgUoo Open-access paper 👉 doi.org/10.1093/ejendo… By DEVI Collaboration/ SIMBA & CoMICs led by @rahulsagu6 European Society of Endocrinology (ESE) ESE_President

#ENEA2024 has started in Seville 🇪🇸 Join us in what will surely be a great and informative meeting! ENEA

Welcome to ENEA 2024! We’re excited to explore the latest in neuroendocrinology with you. Let’s delve into groundbreaking research and foster new collaborations in this fascinating field. #ENEA2024 #Neuroendocrinology ENEA

What an incredible ENEA 2024 Congress 🎉   A massive thank you to all participants, speakers, and organizers for making this event a huge success! 🙌Your contributions have been invaluable, and together, we’re pushing the boundaries of neuroendocrine research   Until next time!

🚨 Exciting news from the EYRC! 🚨 Introducing #NeuroendocrinologyWatch 🧠🔬— every two weeks, we’ll spotlight cutting-edge research in neuroendocrinology. Stay tuned for the latest breakthroughs, insights, and must-read papers! 📄✨ First feature coming soon! 👀 ENEA

🚨 Neuroendocrinology Watch spotlighting Mamelak et al. in JCEM. 1️⃣Surgery for severe cases, but med & surgic. outcomes similar in 100 apoplexy cases 2️⃣Timing of surgery didn’t affect outcomes—expert neurosurgeon transfer is key 3️⃣Med mgmt reduced tumor volume at 3 months

🚨 Neuroendocrinology Watch spotlighting Piña et al. 1⃣ Gene expression annotations align with pathologists' findings. 2⃣Notable intratumor heterogeneity observed in cell clusters. 3⃣Spatial transcriptomics shows promise for small pituitary tumors without multiple stains.

🚨 Neuroendocrinology Watch highlighting the paper by Lin et al in Genome Medicine. 🧠 Key insights: 1️⃣ Single-cell transcriptomics of 23 PitNETs. 2️⃣ Discovery of 5 potential macrophage subtypes. 3️⃣ CX3CR1+ macrophages may induce tumor apoptosis via the INHBA-ACVR1B axis.

PhD rehearsal at #SFE2024 🇫🇷 edition Thank you SFEndocrinologie.org @TLConnan for featuring my presentation Philippe Bertolino Gerald Raverot CRCL Université Lyon 1 HCL | Recherche en santé vimeo.com/1020760452/e61…

Thank you SFEndocrinologie.org SFE President for the Young Investigator Award 🙏

Breastfeeding is recommended at least until a child turns 2 years old. It continues to: ✅ provide important nutrients ✅ build a stronger immune system & protect against obesity. Mums need access to breastfeeding support throughout their #breastfeeding journey.

🔆Neuroendocrinology Watch🔆 New insights on papillary CP treated with BRAF/MEK inh. by Alcubierre et al: 🔹 94% response, with improved headaches, vision & neuro symptoms. 🔹 Tumor volume reduction: 89% (neoadj.), 73% (adj.), 92% (pallia.). 🔹 63% tolerated treatment well

🚨 The 10th EYRC Training Program interview is live! 🎥 Giampaolo Trivellin sat down wit Maria chiara Zatelli , esteemed endocrinologist and ESE secretary, during #ECE2024 in Stockholm. Prof. Zatelli recounted EYRC's founding at ENEA 2012 in Vienna (and yes, there's a parmigiano 🧀 story)!

🔆 Neuroendocrinology Watch 🔆 highlithing Lin B et al., Adv Sci 2024, reveal microbiome-metabolome links in craniopharyngioma. - ↑ Clostridium & disrupted purine metabolism - Hypoxanthine ↔ hypothalamic comorbidities - Redox imbalance fuels CP progression

🔆 Neuroendocrinology Watch 🔆 “Phenotype of Pediatric Cushing Syndrome without Obesity” Padilla C et al., EJE, 2024 • Non-obese patients: older, mostly female, advanced puberty. • Different BP profiles by obesity status. • Weight gain not the only clue—screen for hypercort.